Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Non-Current Assets (2018 - 2025)

AVITA Medical (RCEL) has disclosed Non-Current Assets for 4 consecutive years, with $20.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets fell 7.97% year-over-year to $20.9 million, compared with a TTM value of $86.7 million through Dec 2025, up 31.21%, and an annual FY2025 reading of $20.9 million, down 7.97% over the prior year.
  • Non-Current Assets was $20.9 million for Q4 2025 at AVITA Medical, down from $22.4 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $22.7 million in Q4 2024 and bottomed at $7.1 million in Q3 2023.
  • Average Non-Current Assets over 4 years is $14.5 million, with a median of $13.1 million recorded in 2024.
  • The sharpest move saw Non-Current Assets plummeted 37.62% in 2023, then soared 197.5% in 2024.
  • Year by year, Non-Current Assets stood at $10.8 million in 2022, then dropped by 29.35% to $7.6 million in 2023, then surged by 197.5% to $22.7 million in 2024, then fell by 7.97% to $20.9 million in 2025.
  • Business Quant data shows Non-Current Assets for RCEL at $20.9 million in Q4 2025, $22.4 million in Q3 2025, and $21.9 million in Q2 2025.